| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medicine and Pathology, Arizona Health Sciences Center, and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724 [R. T., C. P., B. D. S., M. R.]; and Celtrix Pharmaceuticals, Inc., Santa Clara, California 94052 [P. S.]
Because limited studies examined effects of transforming growth factor (TGF) ß1 on growth of human acute myelogenous leukemia (AML) cells, we used factor-dependent and primary AML cells to assess TGF-ß1 effects on human AML cell growth. OCI-AML1 cells were growth inhibited by TGF-ß1 regardless of which growth factor was used as a stimulus. In contrast, AML-193 cells were resistant to TGF-ß1 when grown with or without growth factors. UCSD/AML1 cells were sensitive to TGF-ß1 inhibition when grown with most cytokines but were relatively resistant to TGF-ß1 in the presence of macrophage colony-stimulating factor (M-CSF). Although cells grown from 5 of 6 AML patients were inhibited by TGF-ß1, cells from 1 AML patient were growth stimulated by TGF-ß1 in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF), M-CSF, or mast cell growth factor (kit ligand). Thus, 3 growth patterns with TGF-ß1 were observed: (a) sensitivity to growth inhibition; (b) resistance; and (c) factor-dependent resistance. Further studies showed that AML-193 and UCSD/AML1 cells expressed type II TGF-ß1 receptors and that ability of TGF-ß1 to decrease GM-CSF receptors did not correlate with growth inhibition. AML-193 cells and UCSD/AML1 cells grown with M-CSF could be propagated in 1 ng/ml TGF-ß1, but UCSD/AML1 cells grown with GM-CSF and TGF-ß1 died. Morphology and agarose gel analysis of DNA showed UCSD/AML1 cells underwent apoptosis when grown with GM-CSF and TGF-ß1 but not with M-CSF and TGF-ß1. Similar studies of OCI-AML1 cells showed that TGF-ß1 induced apoptosis of cells grown in 5637 bladder cell-conditioned medium or GM-CSF. These studies indicate that human AML cells exhibit heterogeneous growth responses to TGF-ß1 and that some effects of TGF-ß1 on myeloid cells occur through programmed cell death.
1 This work supported in part by NIH National Cancer Institute Grants CA32094 and CA23074.
2 To whom requests for reprints should be addressed, at 1515 N. Campbell Ave., Tucson, AZ 85724.
Received 12/ 7/92. Accepted 5/11/93.
This article has been cited by other articles:
![]() |
G. Ghannam, A. Takeda, T. Camarata, M. A. Moore, A. Viale, and N. R. Yaseen The Oncogene Nup98-HOXA9 Induces Gene Transcription in Myeloid Cells J. Biol. Chem., January 9, 2004; 279(2): 866 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis Blood, September 15, 2000; 96(6): 2022 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Batard, M. Monier, N Fortunel, K Ducos, P Sansilvestri-Morel, T Phan, A Hatzfeld, and J. Hatzfeld TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation J. Cell Sci., January 2, 2000; 113(3): 383 - 390. [Abstract] [PDF] |
||||
![]() |
C. Oliveira, R. Seruca, M. Seixas, and M. Sobrinho-Simoes The Clinicopathological Features of Gastric Carcinomas with Microsatellite Instability May Be Mediated by Mutations of Different ""Target Genes"" : A Study of the TGFß RII, IGFII R, and BAX Genes Am. J. Pathol., October 1, 1998; 153(4): 1211 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saeki, A. Yuo, M. Kato, K. Miyazono, Y. Yazaki, and F. Takaku Cell Density-dependent Apoptosis in HL-60 Cells, Which Is Mediated by an Unknown Soluble Factor, Is Inhibited By Transforming Growth Factor beta 1 and Overexpression of Bcl-2 J. Biol. Chem., August 8, 1997; 272(32): 20003 - 20010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Francis, C. M. Heyworth, E. Spooncer, A. Pierce, T. M. Dexter, and A. D. Whetton Transforming Growth Factor-beta 1 Induces Apoptosis Independently of p53 and Selectively Reduces Expression of Bcl-2 in Multipotent Hematopoietic Cells J. Biol. Chem., December 8, 2000; 275(50): 39137 - 39145. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |